4Liperoti R,Pedone C,Lapane KL,et al.Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents.Arch Intern Med,2005,165(22):2677.
5Cindy K,Pharm D,Min CH.Clozapine and venous thromboembolism.Am J Psychiatry,2002,159 (5):876.
6Hagg S,Spigset O,Soderstrom TG.Association of venous thromboembolism and clozapine.The Lancet,2000,355 (April 1):1155.
7Thomassen R,Vandenbroucke J,Rosendaal FR.Antipsychotic medication and venous thrombosis.British Journal of Psychiatry,2001,179:63.
二级参考文献18
1[1]Vieweg WV. The risks of electrocardiographic QT interval prolongationwhen using antipsychotic drugs. J Clin Psychiatry, 2002, 63(suppl 9): 18.
2[2]De Ponti F, Poluzzi E, Montanoro N. QT interval prolongation by cardiac or non-cardiac facters. Eur J Clin Pharmacol, 2002, 57( 1 ): 1.
3[3]Glassman AH, Bigger JT Jr. Antipsychotic drugs: prolonged QTc interval,torsade de pointes, and sudden death, Am J Psychiatry, 2001, 158(11):1774.
4[4]Pouchelon JL, Martel E, Champeroux P, et al. Effects of clomipramine hydrochloride on heart ratc and rhythm in healthy dogs. Am J Vct Res,2002, 63(8) :960.
5[5]Lentinis S, Rao ML, Schroder R, et al. QT prolongation and torsa de pointes tachycardia during therapy with maprotiline. J Dtsch Med Wochencchr, 2002, 63 (8): 960.
6[6]Partridge SJ, Maclever DH, Solanki T. A depressed myoeardium. J Clin Toxicol, 2002, 40(4):453.
7[7]Pacher P, Magyar J, Szigligeti P, et al. Electro physidogical effects of fluoxetine in mammalian cardiac tissues. J Naunym Schmiedebergs Arch Pharmacol, 2002, 363 ( 1 ): 67.
8[8]Velazquez C, Carlson A, Stokes KA, et al. Relative safety of mirtrazapine overdose. J Vet Hum Toxicol, 2002, 44(6):342.
9[9]Gury C, Canceil O, Iaria P. Antipsychotic drugs and cardiovascular safety. J Encephale, 2001, 27(6):62.
10[10]Ravin DS, Levenson JW. Fatal cardiac event following initiation of risperidone therapy. Ann Pharmacother, 1997, 31 (7- 8):867.
